Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1557595

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1557595

Global Stem Cell Therapy Market 2024-2028

PUBLISHED:
PAGES: 178 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The stem cell therapy market is forecasted to grow by USD 16677.5 mn during 2023-2028, accelerating at a CAGR of 18.69% during the forecast period. The report on the stem cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in awareness of stem cell therapy, and rising regulatory approval for drug development.

Technavio's stem cell therapy market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202416.01%
CAGR18.69%
Incremental Value$16677.5mn

By Application

    • Cancer
    • Musculoskeletal disorder
    • Cardiovascular disease
    • Others

By Type

    • Allogeneic transplants
    • Autologous transplants

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rise in costs of stem cell transplantation as one of the prime reasons driving the stem cell therapy market growth during the next few years. Also, stem cell therapy being potential curative option for chronic diseases and development of ips cells will lead to sizable demand in the market.

The report on the stem cell therapy market covers the following areas:

    • Stem cell therapy market sizing
    • Stem cell therapy market forecast
    • Stem cell therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell therapy market vendors that include Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson Services Inc., Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluri Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp.. Also, the stem cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43432

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Stem Cell Therapy Market 2018 - 2022
    • Historic Market Size - Data Table on Global Stem Cell Therapy Market 2018 - 2022 ($ million)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Cancer - Market size and forecast 2023-2028
    • Chart on Cancer - Market size and forecast 2023-2028 ($ million)
    • Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
    • Chart on Cancer - Year-over-year growth 2023-2028 (%)
    • Data Table on Cancer - Year-over-year growth 2023-2028 (%)
  • 6.4 Musculoskeletal disorder - Market size and forecast 2023-2028
    • Chart on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
    • Data Table on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
    • Chart on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
    • Data Table on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
  • 6.5 Cardiovascular disease - Market size and forecast 2023-2028
    • Chart on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
    • Data Table on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
    • Chart on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
    • Data Table on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
  • 6.6 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 7.3 Allogeneic transplants - Market size and forecast 2023-2028
    • Chart on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
    • Data Table on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
    • Chart on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
    • Data Table on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
  • 7.4 Autologous transplants - Market size and forecast 2023-2028
    • Chart on Autologous transplants - Market size and forecast 2023-2028 ($ million)
    • Data Table on Autologous transplants - Market size and forecast 2023-2028 ($ million)
    • Chart on Autologous transplants - Year-over-year growth 2023-2028 (%)
    • Data Table on Autologous transplants - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Athersys Inc.
    • Athersys Inc. - Overview
    • Athersys Inc. - Product / Service
    • Athersys Inc. - Key offerings
  • 12.4 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 12.5 CRISPR Therapeutics AG
    • CRISPR Therapeutics AG - Overview
    • CRISPR Therapeutics AG - Product / Service
    • CRISPR Therapeutics AG - Key offerings
  • 12.6 Cynata Therapeutics Ltd.
    • Cynata Therapeutics Ltd. - Overview
    • Cynata Therapeutics Ltd. - Product / Service
    • Cynata Therapeutics Ltd. - Key offerings
  • 12.7 FUJIFILM Corp.
    • FUJIFILM Corp. - Overview
    • FUJIFILM Corp. - Business segments
    • FUJIFILM Corp. - Key news
    • FUJIFILM Corp. - Key offerings
    • FUJIFILM Corp. - Segment focus
  • 12.8 Gamida Cell Ltd.
    • Gamida Cell Ltd. - Overview
    • Gamida Cell Ltd. - Product / Service
    • Gamida Cell Ltd. - Key offerings
  • 12.9 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
  • 12.10 Lonza Group Ltd.
    • Lonza Group Ltd. - Overview
    • Lonza Group Ltd. - Business segments
    • Lonza Group Ltd. - Key news
    • Lonza Group Ltd. - Key offerings
    • Lonza Group Ltd. - Segment focus
  • 12.11 Mesoblast Ltd.
    • Mesoblast Ltd. - Overview
    • Mesoblast Ltd. - Product / Service
    • Mesoblast Ltd. - Key offerings
  • 12.12 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 12.13 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 12.14 Pluri Inc.
    • Pluri Inc. - Overview
    • Pluri Inc. - Product / Service
    • Pluri Inc. - Key offerings
  • 12.15 ReNeuron Group plc
    • ReNeuron Group plc - Overview
    • ReNeuron Group plc - Product / Service
    • ReNeuron Group plc - Key offerings
  • 12.16 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 12.17 Vericel Corp.
    • Vericel Corp. - Overview
    • Vericel Corp. - Product / Service
    • Vericel Corp. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
Product Code: IRTNTR43432

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Stem Cell Therapy Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Application - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Application
  • Exhibits35: Data Table on Comparison by Application
  • Exhibits36: Chart on Cancer - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Cancer - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Market opportunity by Application ($ million)
  • Exhibits53: Data Table on Market opportunity by Application ($ million)
  • Exhibits54: Chart on Type - Market share 2023-2028 (%)
  • Exhibits55: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits56: Chart on Comparison by Type
  • Exhibits57: Data Table on Comparison by Type
  • Exhibits58: Chart on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Chart on Autologous transplants - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Autologous transplants - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Autologous transplants - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Autologous transplants - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Market opportunity by Type ($ million)
  • Exhibits67: Data Table on Market opportunity by Type ($ million)
  • Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits71: Chart on Geographic comparison
  • Exhibits72: Data Table on Geographic comparison
  • Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Market opportunity By Geographical Landscape ($ million)
  • Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits111: Impact of drivers and challenges in 2023 and 2028
  • Exhibits112: Overview on criticality of inputs and factors of differentiation
  • Exhibits113: Overview on factors of disruption
  • Exhibits114: Impact of key risks on business
  • Exhibits115: Companies covered
  • Exhibits116: Matrix on companies position and classification
  • Exhibits117: Athersys Inc. - Overview
  • Exhibits118: Athersys Inc. - Product / Service
  • Exhibits119: Athersys Inc. - Key offerings
  • Exhibits120: Bristol Myers Squibb Co. - Overview
  • Exhibits121: Bristol Myers Squibb Co. - Product / Service
  • Exhibits122: Bristol Myers Squibb Co. - Key news
  • Exhibits123: Bristol Myers Squibb Co. - Key offerings
  • Exhibits124: CRISPR Therapeutics AG - Overview
  • Exhibits125: CRISPR Therapeutics AG - Product / Service
  • Exhibits126: CRISPR Therapeutics AG - Key offerings
  • Exhibits127: Cynata Therapeutics Ltd. - Overview
  • Exhibits128: Cynata Therapeutics Ltd. - Product / Service
  • Exhibits129: Cynata Therapeutics Ltd. - Key offerings
  • Exhibits130: FUJIFILM Corp. - Overview
  • Exhibits131: FUJIFILM Corp. - Business segments
  • Exhibits132: FUJIFILM Corp. - Key news
  • Exhibits133: FUJIFILM Corp. - Key offerings
  • Exhibits134: FUJIFILM Corp. - Segment focus
  • Exhibits135: Gamida Cell Ltd. - Overview
  • Exhibits136: Gamida Cell Ltd. - Product / Service
  • Exhibits137: Gamida Cell Ltd. - Key offerings
  • Exhibits138: Johnson and Johnson Services Inc. - Overview
  • Exhibits139: Johnson and Johnson Services Inc. - Business segments
  • Exhibits140: Johnson and Johnson Services Inc. - Key news
  • Exhibits141: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits142: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits143: Lonza Group Ltd. - Overview
  • Exhibits144: Lonza Group Ltd. - Business segments
  • Exhibits145: Lonza Group Ltd. - Key news
  • Exhibits146: Lonza Group Ltd. - Key offerings
  • Exhibits147: Lonza Group Ltd. - Segment focus
  • Exhibits148: Mesoblast Ltd. - Overview
  • Exhibits149: Mesoblast Ltd. - Product / Service
  • Exhibits150: Mesoblast Ltd. - Key offerings
  • Exhibits151: Novartis AG - Overview
  • Exhibits152: Novartis AG - Business segments
  • Exhibits153: Novartis AG - Key news
  • Exhibits154: Novartis AG - Key offerings
  • Exhibits155: Novartis AG - Segment focus
  • Exhibits156: Pfizer Inc. - Overview
  • Exhibits157: Pfizer Inc. - Product / Service
  • Exhibits158: Pfizer Inc. - Key news
  • Exhibits159: Pfizer Inc. - Key offerings
  • Exhibits160: Pluri Inc. - Overview
  • Exhibits161: Pluri Inc. - Product / Service
  • Exhibits162: Pluri Inc. - Key offerings
  • Exhibits163: ReNeuron Group plc - Overview
  • Exhibits164: ReNeuron Group plc - Product / Service
  • Exhibits165: ReNeuron Group plc - Key offerings
  • Exhibits166: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits167: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits169: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits170: Vericel Corp. - Overview
  • Exhibits171: Vericel Corp. - Product / Service
  • Exhibits172: Vericel Corp. - Key offerings
  • Exhibits173: Inclusions checklist
  • Exhibits174: Exclusions checklist
  • Exhibits175: Currency conversion rates for US$
  • Exhibits176: Research methodology
  • Exhibits177: Information sources
  • Exhibits178: Data validation
  • Exhibits179: Validation techniques employed for market sizing
  • Exhibits180: Data synthesis
  • Exhibits181: 360 degree market analysis
  • Exhibits182: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!